Divis Labs surged more than 15 percent intraday as the US Food & Drug Administration will lift import alert 99-32 on the company’s unit-II at Visakhapatnam.
The USFDA had issued an Import Alert under clauses 99-32 and 66-40 in March of 2017 and a warning letter in May of 2017 for Vishakhapatnam facility.
Divi’s Laboratories had filed a detailed responses and given updates to the Form-483 and the warning letter within the stipulated time.
For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co
You may also like:
|Sensex turns sluggish, Nifty still holds 9300; ICICI falls ahead of Q4||Sensex consolidates ahead of FOMC meet outcome; RBL Bank most active|